NEUROCRINE BIOSCIENCES INC (NBIX) Stock Balance Sheet
USA - NASDAQ:NBIX - US64125C1099 - Common Stock
146.85 USD
-0.44 (-0.3%)
146.85 USD
0 (0%)
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 340.20M | 1.08B | 1.03B | 262.90M | 340.80M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 774.60M | 843.10M | 780.50M | 726.40M | 370.50M | |||
| Receivables | 728.00M | 479.10M | 439.30M | 350.00M | 185.50M | |||
| Inventories | 69.30M | 57.40M | 38.30M | 35.10M | 30.50M | |||
| Other Current Assets | 246.30M | 112.10M | 97.80M | 79.10M | 45.50M | |||
| Total Current Assets | 2.16B | 1.72B | 1.61B | 1.45B | 972.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 566.20M | 592.00M | 347.30M | 145.60M | 155.80M | |||
| Investments And Advances | 1.12B | 864.30M | 849.40M | 401.50M | 624.40M | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | 35.70M | 36.50M | 35.50M | 37.20M | null | |||
| Other Non-Current Assets | 388.80M | 501.20M | 412.20M | 330.90M | 319.50M | |||
| Total Non-Current Assets | 2.11B | 1.99B | 1.64B | 915.20M | 1.10B | |||
| TOTAL ASSETS | 4.27B | 3.72B | 3.25B | 2.37B | 2.07B | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | null | 0 | 170.10M | 169.40M | null | |||
| Accrued Expenses | 238.80M | 198.90M | 162.50M | 129.30M | 99.50M | |||
| Accounts Payable | 396.80M | 303.30M | 318.30M | 235.70M | 142.80M | |||
| Other Current Liabilities | 2.40M | 5.50M | 3.90M | 3.30M | 3.50M | |||
| Total Current Liabilities | 638.00M | 507.70M | 654.80M | 537.70M | 245.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 0 | 0 | 335.10M | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 624.10M | 621.30M | 364.60M | 123.20M | 117.60M | |||
| Total Non-Current Liabilities | 624.10M | 621.30M | 364.60M | 123.20M | 452.70M | |||
| TOTAL LIABILITIES | 1.26B | 1.13B | 1.02B | 660.90M | 698.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 294.00M | 29.20M | -157.10M | -406.80M | -635.80M | |||
| Additional Paid In Capital | 2.70B | 2.55B | 2.38B | 2.12B | 2.01B | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | 13.20M | 5.80M | 7.00M | -7.90M | -1.70M | |||
| Shares Outstanding | 99.70M | 99.40M | 98.70M | 96.50M | 94.90M | |||
| Tangible Book Value per Share | 29.7683 | 25.6861 | 22.2543 | 17.3119 | 14.4784 | |||
| Total Shareholders' Equity | 3.00B | 2.59B | 2.23B | 1.71B | 1.37B | |||
| TOTAL LIABILITIES AND EQUITY | 4.27B | 3.72B | 3.25B | 2.37B | 2.07B | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.24 | |||
| Current Ratio | 3.38 | 3.40 | 2.45 | 2.70 | 3.96 | |||
| Return On Assets (ROA) | 10.03% | 9.18% | 7.68% | 6.52% | 4.32% | |||
| Return On Equity (ROE) | 14.25% | 13.18% | 11.19% | 9.05% | 6.52% | |||
| Return On Invested Capital (ROIC) | 11.10% | 13.20% | 11.05% | 9.96% | 8.27% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 16.02% | 32.81% | 36.59% | 21.66% | 13.55% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 16.25% | 33.77% | 38.32% | 22.66% | 13.55% | |||
All data in USD , ROIC based on taxRate of 0.27